ArticleOncology reports2021
[Retracted] Long non‑coding RNA MCM3AP‑AS1 drives ovarian cancer progression via the microRNA‑143‑3p/TAK1 axis.
Article in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MicroRNA‑143‑3p levels are reduced in the peripheral blood of patients with gestational diabetes mellitus and influences pancreatic β‑cell function and viability.Experimental and therapeutic medicine · 2023Article
Corrections and comments
- Retraction of
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of this article, the authors' attention was drawn to the fact that Table I and Fig. 6 contained some errors: The former contained some incorrect data, whereas the latter contained some inappropriately selected tumor images. Following a further investigation in the Editorial Office, it has come to light that there were other possible anomalies associated with the presentation of the tumor images, and also that parts of the figure may have been published previously. Taking everything into consideration, the Editor has decided that the article should be retracted from the publication due to a lack of confidence in the data presented in this article. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not received any reply. The Editor regrets any inconvenience that the retraction of the paper will cause. [the original article was published in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.